Percutaneous aortic valve replacement with a [**Company 1543**]     CoreValve 26-mm device, model number MCS-P3-640, serial     number [**Serial Number 82338**].
History of Present Illness: 81F with critical calcific AS ([**Location (un) 109**] 0.7cm2), AF on coumadin (last dose 2/17), s/p PPM for [**5-16**] for bradycardia/prolonged QT admitted for IV heparin therapy prior to scheduled percutaneous AVR scheduled for Tues [**1-29**].
She denies any chest pain, palpitations, nausea, diaphoresis associated with her shortness of breath with exertion.
Cardiac review of systems is notable for absence of chest pain, dyspnea on exertion, paroxysmal nocturnal dyspnea, orthopnea, ankle edema, palpitations, syncope or presyncope.
CARDIAC RISK FACTORS: Dyslipidemia, Hypertension 2.
CARDIAC HISTORY: -CABG: None -PACING/ICD: - [**Company 1543**] Sensia SEDR01 dual chamber pacemaker with 100% V-paced.
Coumadin  was discontinued, but eventually resumed with no subsequent bleeding.
An aortic CoreValve prosthesis is present.
ADMISSION LABS: [**2115-1-28**] 03:14AM BLOOD WBC-5.0 RBC-3.43* Hgb-10.4* Hct-30.8* MCV-90 MCH-30.4 MCHC-33.8 RDW-13.7 Plt Ct-226 [**2115-1-28**] 03:14AM BLOOD PT-16.8* PTT-150* INR(PT)-1.5* [**2115-1-28**] 03:14AM BLOOD Glucose-90 UreaN-22* Creat-1.8* Na-137 K-5.4* Cl-104 HCO3-23 AnGap-15 [**2115-1-28**] 03:35PM BLOOD ALT-21 AST-39 CK(CPK)-25* AlkPhos-73 TotBili-0.2 [**2115-1-28**] 03:35PM BLOOD proBNP-4007* Discharge labs: [**2115-2-8**] 04:04AM BLOOD WBC-4.9 RBC-3.18* Hgb-9.9* Hct-29.7* MCV-93 MCH-31.0 MCHC-33.3 RDW-14.8 Plt Ct-228 [**2115-2-8**] 04:04AM BLOOD Plt Ct-228 [**2115-2-8**] 04:04AM BLOOD PT-16.0* PTT-27.9 INR(PT)-1.4* [**2115-2-8**] 04:04AM BLOOD Glucose-99 UreaN-21* Creat-1.2* Na-141 K-3.6 Cl-103 HCO3-28 AnGap-14  Radiology Report CHEST (PA & LAT) Study Date of [**2115-2-6**] 11:57 AM Final Report:  In comparison with the study of [**2-4**], there is some mild engorgement of pulmonary vessels suggesting some increasing pulmonary venous pressure in this patient with enlargement of the cardiac silhouette and dual-channel pacemaker device in place.
Brief Hospital Course: 81F with PMH aortic stenosis presents for percutaneous aortic valve replacement.
Pt was admitted preoperatively on [**1-27**] for heart failure optimization and IV heparin bridge.
Percutaneous aortic valve replacement with a [**Company 1543**] CoreValve 26-mm device, model number MCS-P3-640, serial number [**Serial Number 82338**].
She tolerated the procedure well and was trasferred from the operating room to the cardiac surgery ICU in stable condition.
She remained in the ICU for monitoring until POD***.
It should be noted that pre operatively the patient was treated for a urinary tract infection.
and ENTEROCOCCUS SP..  She was seen by the infectious disease service for recommended antibiotic coverage, they felt there was a contaminated culture.
Medications on Admission: WARFARIN -  4 mg Tablet Mo-Fri, 6 mg on Sat (last dose 2/17, last INR 1.5 on [**1-23**]) FOLIC ACID -  (Prescribed by Other Provider) - 1 mg Tablet - 1 Tablet(s) by mouth once a day FUROSEMIDE -  (Prescribed by Other Provider) - 20 mg Tablet - 2 Tablet(s) by mouth daily LOSARTAN [COZAAR] - 50 mg Tablet - 1 Tablet(s) by mouth daily METOPROLOL TARTRATE - 25 mg Tablet - [**12-9**] Tablet(s) by mouth twice daily MIRTAZAPINE [REMERON] -  (Prescribed by Other Provider) - 30 mg Tablet - 1 Tablet(s) by mouth once a day PANTOPRAZOLE -  (Prescribed by Other Provider) - 40 mg Tablet, Delayed Release (E.C.)
- 1 Tablet(s) by mouth twice daily POTASSIUM CHLORIDE -  (Prescribed by Other Provider) - 20 mEq Tab Sust.Rel.
Particle/Crystal - 1 Tab(s) by mouth twice a day SIMVASTATIN -  (Prescribed by Other Provider) - 20 mg Tablet - 1 Tablet(s) by mouth daily SPIRONOLACTONE - 25 mg Tablet - 1 Tablet(s) by mouth daily TRAMADOL [ULTRAM] -  (Prescribed by Other Provider) - 50 mg Tablet - 1 Tablet(s) by mouth twice a day CALCIUM-MAG-VIT B6-D3-MINERALS [CITRACAL PLUS] -  (Prescribed by Other Provider) - Dosage uncertain CYANOCOBALAMIN (VITAMIN B-12) [VITAMIN B-12] -  (Prescribed by Other Provider) - Dosage uncertain FERROUS SULFATE -  (Prescribed by Other Provider) - 325 mg (65 mg iron) Tablet - one Tablet(s) by mouth daily MAGNESIUM OXIDE - 400 mg Tablet - 2 Tablet(s) by mouth daily   Discharge Medications: 1. folic acid 1 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
2. mirtazapine 30 mg Tablet Sig: One (1) Tablet PO HS (at bedtime).
3. simvastatin 10 mg Tablet Sig: Two (2) Tablet PO DAILY (Daily).
5. acetaminophen 325 mg Tablet Sig: 1-2 Tablets PO Q6H (every 6 hours) as needed for fever/pain.
6. tramadol 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for pain.
Disp:*30 Tablet(s)* Refills:*0* 7. aspirin 81 mg Tablet, Delayed Release (E.C.)
9. metoprolol tartrate 25 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
Disp:*60 Tablet(s)* Refills:*2* 10. warfarin 1 mg Tablet Sig: as directed to keep INR 2-2.5 Tablets PO once a day: resume pre procedure coumadin schedule/dosing.
11. furosemide 40 mg Tablet Sig: One (1) Tablet PO twice a day.
Aldactone 25 mg Tablet Sig: One (1) Tablet PO once a day.
13. potassium chloride 10 mEq Tablet Extended Release Sig: Two (2) Tablet Extended Release PO once a day.
Cozaar 25 mg Tablet Sig: One (1) Tablet PO once a day.
Followup Instructions: Provider: [**First Name11 (Name Pattern1) **] [**Initial (NamePattern1) **] [**Last Name (NamePattern1) **], MD Phone:[**Telephone/Fax (1) 62**] Date/Time:[**2115-2-15**] 10:40 Provider:  [**Name10 (NameIs) 676**] CLINIC Phone:[**Telephone/Fax (1) 62**] Date/Time:[**2115-3-13**] 11:00 Provider: [**First Name11 (Name Pattern1) **] [**Last Name (NamePattern4) **], MD Phone:[**Telephone/Fax (1) 62**] Date/Time:[**2115-3-13**] 11:40  Labs: PT/INR Coumadin for atrial fibrillation Goal INR- 2-2.5 First draw- day after discharge Then please do INR checks Monday, Wednesday, and Friday for 2 weeks then decrease as directed by Dr.[**Last Name (STitle) **],[**First Name3 (LF) **] A.
